meta
|
COVID-19
Dynamic meta-analysis of evidences about drug efficacy and safety
611
darunavir/cobicistat plus chloroquine
adjuvant therapies
anticoagulant
anticoagulant, curative dose
anticoagulant, prophylactic dose
anticoagulation, intermediate prophylactic dose
Bivalirudin
heparin at therapeutic dose
sulodexide
colchicine
face mask
febuxostat
hydrogen-oxygen nebulizer
hyperbaric oxygen
nintedanib
pulmonary rehabilitation
thalidomide
vitamin C
anti-inflammatoty and immuno-therapy
acalabrutinib
anti-inflammatory therapies
IFX-1
mepolizumab
naproxen, ibuprofen
non-steroidal anti-inflammatory drugs
Celecoxib
Ibuprofen
Indomethacin
sodium aescinate
Apilimod
corticosteroids
ciclesonide
dexamethasone
Hydrocortisone
inhaled corticosteroids
low-dose corticosteroids
methylprednisolone
imatinib
Immunostimulants drugs
anti-PD-1 antibody
CD24Fc
convalescent plasma treatment
immunoglobulin therapy
emapalumab
inactivated mycobacterium vaccine
interferon
IFN beta-1a
high-dose IFN beta-1a
IFN beta-1b
IFN gamma
inhaled interferon
IFN alpha
recombinant super-compound interferon rSIFN-co
SNG001 inhaled interferon beta
interferon / TFF2
peginterferon
Interleukin-2
neutralizing antibody
AZD7442
bamlanivimab monotherapy
bamlanivimab plus etesevimab
BRII-196 and BRII-198 (Brii Biosciences)
casirivimab and imdevimab (REGN-COV2)
regdanvimab (CT-P59 Celltrion)
VIR-7831 / GSK4182136
rhG-CSF
Vitamin D
Immunosuppressants drugs
adalimumab
anakinra
anti-interleukin-6
clazakizumab
sarilumab
sarilumab azithromycin hydroxychloroquine
sarilumab high dose (400mg)
sarilumab low dose (200mg)
siltuximab
tocilizumab
baricitinib
baricitinib plus remdesivir
eculizumab
jakotinib
lenzilumab
ruxolitinib
tacrolimus
tetrandrine
leflunomide
pirfenidone
Polyinosinic-Polycytidylic Acid
sargramostim
thymosin
antiandrogenic
5-alpha-reductase inhibitors
antiviral and associated therapy
ASC09/ritonavir
azithromycin
azvudine
baloxavir marboxil
carrimycin
chloroquine and derivatives
chloroquine
hydroxychloroquine
danoprevir / ritonavir
darunavir cobicistat
doxycycline
favipiravir
fluvoxamine
hydroxychloroquine plus macrolides
ivermectin
leronlimab
lopinavir / ritonavir plus ribavirin
lopinavir/ritonavir
lopinavir/ritonavir plus chloroquine
lopinavir/ritonavir plus interferon ß-1a
lopinavir/ritonavir, ribavirin and interferon beta-1b
meplazumab
nitazoxanide
oseltamivir
oseltamivir plus chloroquin
remdesivir
Renin-angiotensin-system-acting agents
angiotensin converting enzyme inhibitors (ACEIs)
angiotensin receptor blockers (ARBs)
losartan
angiotensin-(1-7)
continuation of ACEI/ARB
discontinuation of ACEI/ARB
RAS blocker withdrawal
rhACE2
ribavirin
ritonavir
sofosbuvir and daclatasvir
sofosbuvir and ledipasvir
tenofovir/emtricitabine
tenofovir/emtricitabine plus hydroxychloroquine
tranexamic acid
triazavirin
umifenovir (arbidol)
clarithromycine
control
placebo
prone positioning
standard of care
honey
miscellaneous
acetylcysteine
alpha lipoic acid
aviptadil
bevacizumab
bismuth
BLD-2660 (calpain inhibitor)
camostat mesilate
continuous positive airway pressure (CPAP)
cytokine adsorption
diammonium glycyrrhizinate
dipyridamol
DPP-4 inhibitor
enoxaparin
famotidine
kinin-kallikrein inhibitors
lenzilumab
levamisole
metformin
natural killer (NK) cells
nicotin
nitric oxide (gas Inhalation or releasing solution)
ozonated autohemotherapy
pamrevlumab
povidone-iodine
proton pump inhibitors (PPI)
proxalutamide
PUL-042 inhalation solution
radiotherapy
selinexor
statins
tradipitant
tranilast
zinc
vaccines
A EFFACER Janssen Ad.26.COV2.S vaccine (JNJ-78436725)
BBV152 (Bharat Biotech, India)
BCG vaccination
CureVac
DNA vaccine
bacTRL-Spike
Inactivated virus vaccine
CoronaVac (SinoVac)
Covaxin, Bharat Biotech, Indian Council of Medical Research
Sinopharm Beijing (BBIBP-CorV)
Sinopharm Wuhan
Non replicating viral vector
AstraZeneca Oxford (ChAdOx1 nCoV-19)
CanSino
Janssen AD26 vaccine (JNJ-78436735)
Sputnik V (Gam-COVID-Vac)
protein subunit vaccine
Anhui Zhifei Longcom
Novavax (NVX-CoV2373)
RNA vaccine
Moderna COVID-19 vaccine
Pfizer/BIONTECH (tozinameran)
Sanofi/GSK recombinant protein vaccine
SCB-2019
virus-like particles vaccine
Medicago
Zy-Cov-D (Zydus Cadila)
stem cells
All
COVID-19
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 prophylaxis
infections other than COVID-19
preventing respiratory virus transmission